Insiders Updates
Investing in Iterum Therapeutics Plc (ITRM): What You Must Know
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $35000.0 on Dec 22
Menu
Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $35000.0 on Dec 22
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Iterum Therapeutics
The DJIA and S&P 500 tumbled yesterday but both indices recovered some of their mid-day losses to close the day